TeleMation Inc.

CannabisMD TeleMed Helps Patients Access Medical Marijuana in Virginia

Retrieved on: 
Thursday, November 2, 2023

RICHMOND, Va., Nov. 2, 2023 /PRNewswire/ -- CannabisMD TeleMed is a leader in the medical marijuana industry when it comes to helping patients receive their Virginia medical marijuana cards online.

Key Points: 
  • RICHMOND, Va., Nov. 2, 2023 /PRNewswire/ -- CannabisMD TeleMed is a leader in the medical marijuana industry when it comes to helping patients receive their Virginia medical marijuana cards online.
  • They succeeded in their goal of increasing access to medical cannabis by making the process friendly, informative, simple, and affordable.
  • One reason patients choose CannabisMD TeleMed when it comes to getting a medical marijuana certification is that we put patients first and offer a 100% money-back guarantee if a patient does not receive their medical marijuana certification for any reason.
  • If you are interested in receiving access to medical marijuana, then join over 35,000 patients who have chosen CannabisMD TeleMed to connect with a licensed healthcare provider and schedule your medical cannabis evaluation today!

Pluribus Company TeleMED Diagnostic Management Launches 10th Deployment of Proprietary Echo Review and Reporting Module

Retrieved on: 
Tuesday, July 11, 2023

TORONTO, July 11, 2023 /PRNewswire/ - TeleMED Diagnostic Management Inc. ("TeleMED"), a leader in providing medical diagnostic data management solutions, and a part of the Pluribus Technologies (TSXV: PLRB) family, has announced its tenth deployment of its new ViTELflo module for reviewing and reporting Echocardiography ("Echo") and Stress Echocardiography ("Stress Echo") studies.

Key Points: 
  • TORONTO, July 11, 2023 /PRNewswire/ - TeleMED Diagnostic Management Inc. ("TeleMED"), a leader in providing medical diagnostic data management solutions, and a part of the Pluribus Technologies (TSXV: PLRB) family, has announced its tenth deployment of its new ViTELflo module for reviewing and reporting Echocardiography ("Echo") and Stress Echocardiography ("Stress Echo") studies.
  • "Each deployment has been a result of word-of-mouth communication among the tightly knit cardiologist community", said Diane Pedreira, Chief Operating Officer of TeleMED.
  • ViTELflo, TeleMED's proprietary management platform, had already proven itself capable of handling these issues in the community lab environment.
  • However, to offer a complete solution to cardiology clinics, TeleMED engineers needed to develop a module for managing clinically important, high value Echo and Stress Echo studies.

CETVNOW, a New Provider of Commercial Environment TV Ads, Has Made Its Debut

Retrieved on: 
Thursday, September 29, 2022

PHOENIX, Sept. 29, 2022 /PRNewswire/ -- CETVNOW, an all-new television advertising provider from Telemated, has officially launched. The company has created innovative targeted ad delivery technology that allows clients to promote products and services in real-time, specifically reaching consumers at the buying moment within commercial establishments.

Key Points: 
  • PHOENIX, Sept. 29, 2022 /PRNewswire/ --CETVNOW, an all-new television advertising provider from Telemated, has officially launched.
  • The company has created innovative targeted ad delivery technology that allows clients to promote products and services in real-time, specifically reaching consumers at the buying moment within commercial establishments.
  • Marketing experts anticipate that CETVNOW will spark a significant shift within the industry by redefining the possibilities of television advertising.
  • Throughout this testing period, the company implemented ongoing improvements and enhancements with the goal of exceeding the industry standard.

SOC Telemed Stockholders Approve Acquisition by Patient Square Capital

Retrieved on: 
Monday, April 4, 2022

HERNDON, Va., April 4, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced that its stockholders approved the acquisition of SOC Telemed by Patient Square Capital, a leading dedicated health care investment firm, at a special meeting.

Key Points: 
  • HERNDON, Va., April 4, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced that its stockholders approved the acquisition of SOC Telemed by Patient Square Capital, a leading dedicated health care investment firm, at a special meeting.
  • Steve Shulman, Chairman of the SOC Telemed Board of Directors, said, "On behalf of the SOC Telemed Board, I would like to thank our stockholders for their support of this transaction.
  • SOC Telemed ("SOC") is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004.
  • Patient Square Capital is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health.

SOC Telemed Appoints New National Medical Director for Maternal-Fetal Medicine

Retrieved on: 
Friday, February 18, 2022

She joined the telemedicine group in 2020 after a traditional medical career as part of a large Austin, Texas-based physician practice.

Key Points: 
  • She joined the telemedicine group in 2020 after a traditional medical career as part of a large Austin, Texas-based physician practice.
  • "I'm honored to serve as SOC Telemed's national medical director for this high-growth service line and bring MFM expertise to more women and babies in more communities."
  • SOC Telemed's teleMFM programs deliver care in inpatient and outpatient settings, including hospitals, community-based OB/GYN practices, and radiology and imaging practices.
  • SOC Telemed ("SOC") is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004.

NOBLE Study Brings Advanced Prostate Imaging to Rural Australia – First Patient Dosed

Retrieved on: 
Sunday, November 14, 2021

MELBOURNE, Australia, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first Australian patient has been dosed in the international NOBLE Registry, a global study that aims to improve access for men to state-of-the-art prostate cancer imaging tools.

Key Points: 
  • MELBOURNE, Australia, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first Australian patient has been dosed in the international NOBLE Registry, a global study that aims to improve access for men to state-of-the-art prostate cancer imaging tools.
  • The NOBLE (Nobody Left Behind) Registry is collecting clinical data to inform the development of TLX599-CDx (99mTc-iPSMA), an investigational prostate cancer imaging agent that targets PSMA (prostate specific membrane antigen) using single photon emission computed tomography (SPECT).
  • Our involvement in NOBLE takes us a step closer to achieving this, by giving patients local access to the latest prostate cancer imaging tools which could have a profound impact on clinical decisions regarding their treatment.
  • The NOBLE Registry is being conducted at nine sites globally, with a site in Jakarta, Indonesia now added to the study.

SOC Telemed to Provide Corporate and Financial Update for the Third Quarter 2021 on November 12, 2021

Retrieved on: 
Friday, October 29, 2021

The live conference call and replay can also be accessed via audio webcast at the Investor Relations section of the Company's website, located at SOC Telemed Investor Relations - Home .

Key Points: 
  • The live conference call and replay can also be accessed via audio webcast at the Investor Relations section of the Company's website, located at SOC Telemed Investor Relations - Home .
  • SOC Telemed (NASDAQ: TLMD)is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004.
  • Built on proven and scalable infrastructure as an enterprise-wide solution, SOC's technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care.
  • SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health.

SOC Telemed and Ob Hospitalist Group Announce Nationwide Partnership

Retrieved on: 
Thursday, September 16, 2021

RESTON, Va., Sept. 16, 2021 /PRNewswire/ -- SOC Telemed (NASDAQ: TLMD), the largest national provider of acute care telemedicine, and Ob Hospitalist Group (OBHG ) , the nation's largest and only dedicated provider of customized obstetric (OB) hospitalist programs, today announced a collaboration combining OBHG's leading OB hospitalist programs with SOC Telemed's maternal-fetal medicine (MFM) experts.

Key Points: 
  • RESTON, Va., Sept. 16, 2021 /PRNewswire/ -- SOC Telemed (NASDAQ: TLMD), the largest national provider of acute care telemedicine, and Ob Hospitalist Group (OBHG ) , the nation's largest and only dedicated provider of customized obstetric (OB) hospitalist programs, today announced a collaboration combining OBHG's leading OB hospitalist programs with SOC Telemed's maternal-fetal medicine (MFM) experts.
  • The combined OB hospitalist/teleMFM offering is currently expanding to additional OBHG hospital partner sites nationwide.
  • The new partnership enables patients to receive 24/7 onsite care from OBHG's skilled OB physicians and access to SOC Telemed's MFM physicians.
  • The program is designed to complement the in-person physician care delivered by the OB hospitalists with care recommendations from the remote MFMs.

SOC Telemed Announces Departure of CFO, Chris Knibb

Retrieved on: 
Wednesday, September 15, 2021

RESTON, Va., Sept. 15, 2021 /PRNewswire/ --SOC Telemed, Inc. (NASDAQ: TLMD, "SOC"), the largest national provider of acute care telemedicine, today announced that Chris Knibb, Chief Financial Officer (CFO), has resigned to pursue other opportunities effective September 23, 2021.

Key Points: 
  • RESTON, Va., Sept. 15, 2021 /PRNewswire/ --SOC Telemed, Inc. (NASDAQ: TLMD, "SOC"), the largest national provider of acute care telemedicine, today announced that Chris Knibb, Chief Financial Officer (CFO), has resigned to pursue other opportunities effective September 23, 2021.
  • "I appreciate Chris' leadership and impact on the SOC team," said Dr. Chris Gallagher, Chief Executive Officer of SOC Telemed.
  • David Fletcher will serve as the Interim Chief Financial Officer of SOC Telemed.
  • SOC Telemed assumes no obligation, and does not intend, to update these forward-looking statements as a result of future events or developments, except as required by law.

SOC Telemed Announces Introductory Conference Call with New Leadership

Retrieved on: 
Tuesday, September 7, 2021

RESTON, Va., Sept. 7, 2021 /PRNewswire/ --SOC Telemed, Inc. (NASDAQ: TLMD), the largest national provider of acute care telemedicine, today announced that the Company will host an introductory conference call with new leadership, which was announced on September 1, 2021.

Key Points: 
  • RESTON, Va., Sept. 7, 2021 /PRNewswire/ --SOC Telemed, Inc. (NASDAQ: TLMD), the largest national provider of acute care telemedicine, today announced that the Company will host an introductory conference call with new leadership, which was announced on September 1, 2021.
  • A live audio webcast will be available on the Investor Relations section of the Company website at investors.soctelemed.com.
  • SOC Telemed (NASDAQ: TLMD) is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004.
  • Build on proven and scalable infrastructure as an enterprise-wide solution, SOC's technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care.